Fifth Third Bancorp
CORT icon

Fifth Third Bancorp’s Corcept Therapeutics CORT Stock Holding History

Fifth Third Bancorp’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.51M Buy
51,914
+14,672
+39% +$886K 0.01% 837
2026
Q1 		$1.5M Buy
37,242
+33,448
+882% +$1.25M ﹤0.01% 1379
2025
Q4 		$132K Buy
3,794
+3,046
+407% +$239K ﹤0.01% 1097
2025
Q3 		$62.2K Buy
748
+42
+6% +$3.04K ﹤0.01% 1404
2025
Q2 		$51.8K Sell
706
-51
-7% -$3.7K ﹤0.01% 1392
2025
Q1 		$86.5K Buy
757
+139
+22% +$8.46K ﹤0.01% 1209
2024
Q4 		$31.1K Sell
618
-9
-1% -$472 ﹤0.01% 1576
2024
Q3 		$29K Buy
627
+59
+10% +$2.1K ﹤0.01% 1641
2024
Q2 		$18.5K Buy
568
+81
+17% +$2.22K ﹤0.01% 1741
2024
Q1 		$12.3K Buy
487
+20
+4% +$473 ﹤0.01% 1814
2023
Q4 		$15.2K Hold
467
– – ﹤0.01% 1852
2023
Q3 		$12.7K Hold
467
– – ﹤0.01% 1885
2023
Q2 		$10.4K Hold
467
– – ﹤0.01% 1970
2023
Q1 		$10.1K Buy
467
+147
+46% +$3.22K ﹤0.01% 2094
2022
Q4 		$6.5K Sell
320
-48
-13% -$1.2K ﹤0.01% 2105
2022
Q3 		$9K Buy
368
+83
+29% +$2.22K ﹤0.01% 1979
2022
Q2 		$7K Sell
285
-48
-14% -$1.05K ﹤0.01% 2120
2022
Q1 		$7K Buy
333
+204
+158% +$4.34K ﹤0.01% 2171
2021
Q4 		$3K Buy
129
+28
+28% +$568 ﹤0.01% 2473
2021
Q3 		$2K Buy
+101
New +$2.11K ﹤0.01% 2431
2021
Q2 		– Sell
-253
Closed -$6K – 2436
2021
Q1 		$6K Buy
+253
New +$6.75K ﹤0.01% 2139
2019
Q1 		– Sell
-24,832
Closed -$332K – 2170
2018
Q4 		$332K Sell
24,832
-16,620
-40% -$220K ﹤0.01% 723
2018
Q3 		$581K Buy
41,452
+9,701
+31% +$136K ﹤0.01% 645
2018
Q2 		$499K Sell
31,751
-1,460
-4% -$25.4K ﹤0.01% 690
2018
Q1 		$546K Buy
+33,211
New +$615K ﹤0.01% 660

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fifth Third Bancorp's CORT Position: Q2 2026 in Review

Fifth Third Bancorp increased its Corcept Therapeutics (CORT) stake by 39% in Q2 2026, buying an estimated $886K and bringing the position to 51,914 shares worth $4.51M. The position accounts for 0.01% of the portfolio, ranked #837.

Fifth Third Bancorp first reported a position in CORT in Q1 2018 and has held it in 25 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Fifth Third Bancorp held 51,914 shares of Corcept Therapeutics worth $4.51M as of Q2 2026.
  • Fifth Third Bancorp bought 14,672 Corcept Therapeutics shares in Q2 2026, an estimated $886K.
  • Corcept Therapeutics made up 0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #837 holding.
  • Fifth Third Bancorp first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 25 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.